Joerg Lahann and Maria Castro, U-M faculty researchers, discuss the development of a new nanomedicine to help treat the most aggressive type of brain cancer, glioblastoma. The nanomedicine is delivered less invasively through the bloodstream, and after crossing the blood-brain barrier, it engages the immune system and kills cancer cells. Researchers are hoping to test out the nanomedicine on mice to determine how much makes it to the brain, its ability to fight cancer, its side effects, and how well it leaves the body. The faculty experts further highlight the process and development behind the research.
Use code BLUE125 to save big on select memberships!